RENFLEXIS (INFLIXIMAB-ABDA) — FDA Approval BLA761054 (SAMSUNG BIOEPIS CO LTD)
RENFLEXIS (INFLIXIMAB-ABDA) — FDA Approval BLA761054 (SAMSUNG BIOEPIS CO LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: RENFLEXIS; Active ingredients: INFLIXIMAB-ABDA; Application number: BLA761054.
| Brand name | RENFLEXIS |
|---|---|
| Active ingredients | INFLIXIMAB-ABDA |
| Application number | BLA761054 |
| Sponsor | SAMSUNG BIOEPIS CO LTD |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20170421 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →